entertainment -WSS

entertainment

author：fashion 2025-09-30 00:46:42 - browse：919

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： UpToDate has a racism problem: Dr. Stanley Goldfarb

explore

WSS

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Lupron, used to halt puberty in children, may cause lasting health problems

Pumping milk in bathrooms at health conferences is common

High breast density mammograms need follow

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Undocumented workers face uncertainty as immigration law takes effect in Florida

hotspot

entertainment

Wikipedia

How to save PrEP access — and even expand it

Hubble vs. James Webb telescope images: See the difference

Supreme Court strikes down use of affirmative action

Printout prescription drug information shouldn’t go digital

Medical leaders decry Supreme Court decision on affirmative action

A letter from the executive editor: The 2023 STATUS List

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Crowdfunding for unproven stem cell procedures spreads misinformation

Drug repurposing or repositioning? The language matters

Head of FDA's diagnostics center, who led through Covid, retires

explore

Security flaws in third

Hubble vs. James Webb telescope images: See the difference

Immunocompromised patients offer clues on chronic Covid

The inclusion problem at the heart of rehabilitation research

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Update the Apgar Score to remove skin color

explore

entertainment

hotspot

explore